cytidine triphosphate has been researched along with Alopecia Areata in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braman, V; Bruce, S; Cassella, JV; Colavincenzo, M; Guttman-Yassky, E; Hamilton, C; Kempers, S; King, B; McMichael, A; Mesinkovska, N; Mirmirani, P; Roberts, JL | 1 |
1 trial(s) available for cytidine triphosphate and Alopecia Areata
| Article | Year |
|---|---|
Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata.
Topics: Adult; Alopecia Areata; Cytidine Triphosphate; Humans; Janus Kinase Inhibitors; Pyrimidines; Treatment Outcome | 2022 |